CLOV
$1.93
Clover Health Investments, Corp.
Recent News
Clover Health Investments Touts AI Medicare Advantage Model, Targets GAAP Profitability in 2026 at Leerink Conference
Clover Health Investments (NASDAQ:CLOV) executives outlined what they described as a repeatable, technology-driven Medicare Advantage model at the Leerink Global Healthcare Conference, emphasizing high member retention, cohort profitability dynamics, and expanding use cases for its software beyond t
1 Unprofitable Stock for Long-Term Investors and 2 We Ignore
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
Clover Health (CLOV) Valuation Check After TEFCA Milestone And Profitability Guidance
Clover Health Investments (CLOV) is back in focus after announcing it is the first payer live on a CMS Aligned Network and TEFCA, enabling real time, nationwide exchange of standardized clinical and claims data. See our latest analysis for Clover Health Investments. The new interoperability milestone comes after a mixed share price run, with an 8% 1 day share price return and a 3.35% 7 day gain, but a 90 day share price return showing an 18.8% decline and a 1 year total shareholder return...
Clover Health Enters Collaboration to Be Part of CMS Aligned Network
CLOV jumped 8% after partnering with Kno2 to become the first payer live on a CMS Aligned Network, enabling real-time patient access to clinical and claims data.
1 Cash-Heavy Stock with Impressive Fundamentals and 2 We Ignore
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.